20. Vaxxinova Founded Year: 2010 Headquarters: Nijmegen, The Netherlands 19. Vetpolis Founded Year: 2022 Headquarters: Panchkula, India 18. Audevard Laboratoires Founded Year: 1986 Headquarters: Clichy, France 17. Rodec Pharma Founded Year: 1998 Headquarters: Ghaziabad, India 16. Teco...
Quick Takeaways: Why It Matters? The EUAs immediately expand the therapeutic toolkit for a serious, fast-moving parasitic threat, positioning NexGard and NexGard COMBO as go‑to options if New World screwworm spreads beyond current foci in northern Mexico.&nb...
Quick Takeaways Why It Matters? The partnership allows GekkoVet to scale rapidly in a new geography by leveraging Royal Canin’s established veterinary relationships, positioning its AI platform as an embedded part of day-to-day clinical practice. For R...
Quick Takeaways: Why It Matters? BE-101’s move into pivotal field safety testing brings the poultry sector closer to a commercially viable, non-antibiotic solution for necrotic enteritis, addressing a major economic and welfare burden while aligning with global pressure to...
Quick Takeaways Why It Matters? The merger creates one of the most integrated players in animal health, combining physical distribution, practice software, and pharmacy services into a single, tech-enabled platform that can embed itself deeply in veterinary workflows. Vet...
Quick Takeaways Why It Matters? CompanAIn taps into the growing demand for continuous, between-visit pet health management, positioning itself as a data hub that complements rather than replaces veterinary care. By unifying home observations with medical and lab data...
Quick Takeaways: Why It Matters? Full approval elevates KBroVet from a conditional option to the reference standard for potassium bromide in canine idiopathic epilepsy, giving vets greater confidence in its long‑term use. Its once‑daily, chewable, liver...
Quick Takeaways Why It Matters? Loyal’s raise reinforces longevity as a serious, institution-backed frontier in veterinary medicine, moving it from niche concept to an emerging preventive care category. If LOY-002 secures conditional and then full approval, it could...
Quick Takeaways: Why It Matters? MUMS status gives Masivet a clearer US regulatory and commercial path, adding potential 7‑year market exclusivity and grant support on top of its established European use, which should enhance the asset’s value as AB Science courts par...
Quick Takeaways: Why It Matters? Data for LPT‑CBD strengthens the scientific case for long‑acting, injectable CBD as a legitimate chronic pain option, not just a wellness supplement, which can increase veterinarian openness to cannabinoid-based therapies. The sustaine...
